Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAVI Global Trust Regulatory News (AGT)

Share Price Information for AVI Global Trust (AGT)

Share Price is delayed by 15 minutes
Get Live Data
263.00    1.00 (0.38%)
Bid:
263.00
Ask:
263.50
Spread: 0.50 (0.19%)
Market Cap: £1.05b
AGT Live PriceLast checked at - London Stock Exchange

Intraday AVI Global Trust Share Chart

Monthly Factsheet

10 Mar 2026 16:42

RNS Number : 1059W
AVI Global Trust PLC
10 March 2026
 

 

AVI GLOBAL TRUST PLC

 

Monthly Update

 

AVI Global Trust plc (the "Company") presents its Update, reporting performance figures for the month ended 28 February 2026.

 

This Monthly Newsletter is available on the Company's website at: AGT-FEBRUARY-2026.pdf

 

This investment management report relates to performance figures to 28 February 2026.

 

Total Returns (%)

Month

1Y

5Y

10Y

NAV p/s1

3.6

12.1

62.7

242.8

MSCI ACWI2

3.4

16.3

81.0

251.0

MSCI ACWI ex US2

7.2

30.8

65.7

180.9

 

All performance shown net of fees in GBP Total Return as at 28/02/2026.

1Net Asset Value cum-fair.

2From 1st October 2023, the comparator benchmark was changed to the MSCI ACWI Index. Prior to this, from 1st October 2013, the comparator benchmark was the MSCI ACWI ex US Index.

Source: Morningstar, S&P Capital IQ

 

Manager's Comment

AGT's NAV increased by +3.6% in February 2026.

Performance was broad-based with Samsung C&T (+105bps) the standout performer, followed by Jardine Matheson (+85bps) and HD Hyundai (+65bps). Indeed, it is interesting to observe that the nine largest contributors were all listed in Asia and delivered returns between +9% and +25%.

At the bottom of the table was Chrysalis, shares in which declined -13% over the month, shaving off -93bps from NAV. News Corp (-54bps) and Vivendi (-33bps) also detracted.

Over the month we took some profit in Samsung C&T and HD Hyundai as discounts narrowed and underlying valuations rose. We have also continued to clean up the tail: we sold the last of our shares in Gerresheimer, which had been a heavily loss making and bruising investment where the original investment thesis was no longer valid, whilst also fully exiting Entain. We have continued to add to EXOR - on close to its widest ever discount - and added to News Corp on weakness.

March Market Commentary

 

Writing on the 9th of March, February already feels but a distant memory, as geopolitical tension in the Middle East has moved beyond rhetoric, following coordinated joint attacks on Iran from the US and Israel. This has led to considerable volatility in global equity markets, with emerging market equities and currencies suffering their worse week since the pandemic.

 

Korea- which accounted for 18% of NAV at the end of February has been at the centre of this, with the Kospi down -16% so far in March. In many ways this doesn't surprise us - it had been the best performing stock market of the last year, up +72%- and was likely to suffer from profit taking and risk appetite reduction in a market correction. That said, the extent of some share price declines and discount moves have been quite staggering.

 

Despite this we remain relatively sanguine: In Korea we have assembled a collection of ten diverse holdings, with strong earnings growth prospects, trading on very wide discounts, and set to benefit from improved governance reform. On the latter, progress continues with the third amendment to the Commercial Act having passed at the end of February 2026, which will see all existing treasury shares cancelled within 18 months and newly bought back shares cancelled within one year. Although an imperfect analogy, our experience from Japan- looking through the noise, focussing on the fundamentals and the prize on offer through governance reform- helps navigate such an environment.

Whether the war in the Middle East transpires into a longer and more protracted conflict remains to be seen. The economic impact will depend upon the extent of disruption to energy markets and shipping routes, which have the potential to lower growth and increase inflation. In the last few days, the market has started to price more severe energy disruption as a more meaningful possibility, with sharp declines in equities and oil breaching $110 per barrel.

As is common in times of market stress, discounts have widened serving as an additional headwind to NAV weakness. At the time of writing the portfolio weighted average discount stands just 2008 financial crisis, the Eurozone crisis and Covid-2020. north of 40%- a level previously observed during the 2008 financial crisis, the Eurozone crisis and Covid-2020.

Whilst discounts can move wider, such levels do not typically persist for long periods of time. Such volatility is painful in the short-term, however, in the long-run, it gives rise to great opportunity. As we will come onto below, following the sale of Toyota Industries, AGT is now in a net cash position and has ~£170m of available fire power. This leaves us well positioned to take advantage of exaggerated share price and discount moves.

Toyota Industries

In last month's newsletter we discussed how we had recently made Toyota Industries the largest position, reflecting what we perceived to be an asymmetric set up.

After month end it was announced that Toyota Group had raised its offer for Toyota Industries by +10% to 20,600 Yen per share, a 26% increase from its initial bid. This latest bid is in line with the Company's book value, and whilst undoubtedly an attractive price for the acquirers, represents a much fairer outcome for minority shareholders. It also represents an important milestone for Japanese corporate governance reform, and the power of activism in Japan.

Following the higher bid, we sold the entirety of the position, generating proceeds just north of £100m, or almost 9% of AGT's NAV. In doing-so, gearing has reduced from ~5% at February month end to ~4% net cash.

Having re-initiated a position in Toyota Industries in 2023, over the course of the investment it generated an IRR of +30% (in Yen), compared to -8% for the TOPIX and +19% for the MSCI AC World Index (also in Yen).

Contributors / Detractors (in GBP)4

 

Largest Contributors

1- month contribution

bps

% Weight3

Samsung C&T

105

5.0

Jardine Matheson

85

6.0

HD Hyundai

65

2.3

Kyocera Corp

59

3.6

Mitsubishi Logistics

48

5.4

 

Largest Detractors

1- month contribution

bps

% Weight3

Chrysalis Investments

-93

6.0

News Corp A

-54

5.9

Vivendi

-33

5.5

Oakley Capital Investments

-27

3.3

D'Ieteren

-26

6.8

 

3All Figures shown as % of Net Asset Value

4Contributors and detractors from Factset

 

 

MUFG Corporate Governance Limited

Corporate Secretary

 

10 March 2026

 

LEI: 213800QUODCLWWRVI968

 

The content of the Company's web-pages and the content of any website or pages which may be accessed through hyperlinks on the Company's web-pages, other than the content of the Newsletter referred to above, is neither incorporated into nor forms part of the above announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDZGMFVGGGVZM
Date   Source Headline
4th Jun 20261:04 pmRNSNet Asset Value(s)
4th Jun 20267:00 amRNSHalf-year Financial Report
3rd Jun 20261:50 pmRNSNet Asset Value(s)
2nd Jun 20261:23 pmRNSNet Asset Value(s)
1st Jun 20265:17 pmRNSTransaction in Own Shares
1st Jun 20262:58 pmRNSNet Asset Value(s)
1st Jun 202610:22 amRNSTotal Voting Rights
29th May 202611:31 amRNSNet Asset Value(s)
28th May 20261:55 pmRNSNet Asset Value(s)
27th May 20265:05 pmRNSTransaction in Own Shares
27th May 20262:54 pmRNSNet Asset Value(s)
26th May 20265:41 pmRNSTransaction in Own Shares
26th May 20261:15 pmRNSNet Asset Value(s)
22nd May 20265:12 pmRNSTransaction in Own Shares
22nd May 20261:20 pmRNSNet Asset Value(s)
21st May 20265:11 pmRNSTransaction in Own Shares
21st May 202611:56 amRNSNet Asset Value(s)
20th May 20261:55 pmRNSNet Asset Value(s)
19th May 20265:17 pmRNSTransaction in Own Shares
19th May 202611:43 amRNSNet Asset Value(s)
18th May 20261:06 pmRNSNet Asset Value(s)
15th May 202612:20 pmRNSNet Asset Value(s)
14th May 20262:21 pmRNSMonthly Factsheet
14th May 20261:03 pmRNSNet Asset Value(s)
13th May 202612:51 pmRNSNet Asset Value(s)
12th May 20261:38 pmRNSNet Asset Value(s)
11th May 20265:30 pmRNSTransaction in Own Shares
11th May 20261:37 pmRNSNet Asset Value(s)
8th May 20261:43 pmRNSNet Asset Value(s)
7th May 20265:30 pmRNSTransaction in Own Shares
7th May 202612:42 pmRNSNet Asset Value(s)
6th May 20265:23 pmRNSTransaction in Own Shares
6th May 202612:32 pmRNSNet Asset Value(s)
5th May 20261:12 pmRNSNet Asset Value(s)
1st May 202612:33 pmRNSNet Asset Value(s)
1st May 20269:58 amRNSTotal Voting Rights
30th Apr 20261:45 pmRNSNet Asset Value(s)
29th Apr 20265:37 pmRNSTransaction in Own Shares
29th Apr 202612:23 pmRNSNet Asset Value(s)
28th Apr 20265:12 pmRNSTransaction in Own Shares
28th Apr 202612:18 pmRNSNet Asset Value(s)
27th Apr 20265:09 pmRNSTransaction in Own Shares
27th Apr 20261:10 pmRNSNet Asset Value(s)
27th Apr 202610:30 amRNSCompliance with Market Abuse Regulations
24th Apr 20265:05 pmRNSTransaction in Own Shares
24th Apr 202612:25 pmRNSNet Asset Value(s)
23rd Apr 202612:53 pmRNSNet Asset Value(s)
22nd Apr 20263:10 pmRNSNet Asset Value(s)
21st Apr 20265:10 pmRNSTransaction in Own Shares
21st Apr 202612:54 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.